UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER
๐บ๐ธUnited States
- Country
- ๐บ๐ธUnited States
- Ownership
- -
- Established
- 1943-01-01
- Employees
- 8.1K
- Market Cap
- -
'Prognostic Value of Hyperpolarized 13C MRI for Clinical Myocardial Viability
Recruiting
- Conditions
- Ventricular Function, LeftMyocardial Perfusion Imaging
- First Posted Date
- 2023-09-21
- Last Posted Date
- 2024-10-16
- Lead Sponsor
- University of Texas Southwestern Medical Center
- Target Recruit Count
- 30
- Registration Number
- NCT06047028
- Locations
- ๐บ๐ธ
University of Texas Southwestern Medical Center, Dallas, Texas, United States
PSMA PET Response Guided SabR in High Risk Pca
Phase 1
Recruiting
- Conditions
- Prostate Adenocarcinoma
- Interventions
- Drug: 68-Ga PSMA11
- First Posted Date
- 2023-09-21
- Last Posted Date
- 2024-03-12
- Lead Sponsor
- University of Texas Southwestern Medical Center
- Target Recruit Count
- 20
- Registration Number
- NCT06044857
- Locations
- ๐บ๐ธ
University of Texas Southwestern Medical Center, Dallas, Texas, United States
๐บ๐ธUT Southwestern Medical Center, Dallas, Texas, United States
DIALYSIS-TIR Study
Phase 4
Recruiting
- Conditions
- End Stage Renal Disease on DialysisType 2 Diabetes
- Interventions
- Drug: PlaceboDrug: Semaglutide
- First Posted Date
- 2023-09-18
- Last Posted Date
- 2024-02-13
- Lead Sponsor
- University of Texas Southwestern Medical Center
- Target Recruit Count
- 157
- Registration Number
- NCT06042153
- Locations
- ๐บ๐ธ
Davita UT Southwestern - Oak Cliff, Dallas, Texas, United States
๐บ๐ธUniversity of North Carolina, Chapel Hill, North Carolina, United States
๐บ๐ธDaVita UT Southwestern - East Dallas, Dallas, Texas, United States
Evaluating Intercostobrachial Nerve Block's Effect on Pain Control After Shoulder Replacement
Not Applicable
- Conditions
- Shoulder PainPostoperative Pain, Acute
- Interventions
- Procedure: intercostobrachial nerve block
- First Posted Date
- 2023-09-18
- Last Posted Date
- 2024-11-05
- Lead Sponsor
- University of Texas Southwestern Medical Center
- Target Recruit Count
- 74
- Registration Number
- NCT06042608
- Locations
- ๐บ๐ธ
University of Texas Southwestern Medical Center, Dallas, Texas, United States
Pressure Alternating Shoes (PAS) for Prevention of Diabetic Foot Ulcers
Not Applicable
Completed
- Conditions
- Foot Ulcer, Diabetic
- Interventions
- Device: test pressure alternating shoes
- First Posted Date
- 2023-09-07
- Last Posted Date
- 2024-12-04
- Lead Sponsor
- University of Texas Southwestern Medical Center
- Target Recruit Count
- 4
- Registration Number
- NCT06026813
- Locations
- ๐บ๐ธ
University of Texas Southwestern Medical Center, Dallas, Texas, United States
Transcutaneous Tibial Nerve Stimulation (TTNS) Treatment in Spina Bifida Pediatric Patients With Neurogenic Bladder
Not Applicable
Not yet recruiting
- Conditions
- Spina Bifida
- Interventions
- Device: Transcutaneous Tibial Nerve Stimulation (TTNS) treatment
- First Posted Date
- 2023-09-06
- Last Posted Date
- 2024-12-02
- Lead Sponsor
- University of Texas Southwestern Medical Center
- Target Recruit Count
- 12
- Registration Number
- NCT06025734
EGCG for Hepatocellular Carcinoma Chemoprevention
Phase 2
Recruiting
- Conditions
- Cirrhosis, Liver
- Interventions
- Other: PlaceboDrug: Epigallocatechin gallate (EGCG)
- First Posted Date
- 2023-08-29
- Last Posted Date
- 2024-11-07
- Lead Sponsor
- University of Texas Southwestern Medical Center
- Target Recruit Count
- 60
- Registration Number
- NCT06015022
- Locations
- ๐บ๐ธ
UT Southwestern, Dallas, Texas, United States
Studying the Health of Asians to Advance Knowledge, Treatments, and Interventions for Depression
Recruiting
- Conditions
- Treatment Resistant DepressionBipolar DisorderMental DisordersBipolar and Related DisordersDepressionMood Disorders
- Interventions
- Other: Observational Study
- First Posted Date
- 2023-08-21
- Last Posted Date
- 2024-08-13
- Lead Sponsor
- University of Texas Southwestern Medical Center
- Target Recruit Count
- 6000
- Registration Number
- NCT06002204
- Locations
- ๐บ๐ธ
UT Southwestern Medical Center, Dallas, Texas, United States
EffCaMgCit to Prevent Mineral Metabolism and Renal Complications of Chronic PPI Therapy
Phase 3
Recruiting
- Conditions
- OsteoporosisHypomagnesemia
- Interventions
- Drug: EffCaMgCitOther: Placebo
- First Posted Date
- 2023-08-21
- Last Posted Date
- 2024-05-22
- Lead Sponsor
- University of Texas Southwestern Medical Center
- Target Recruit Count
- 56
- Registration Number
- NCT05998863
- Locations
- ๐บ๐ธ
University of Texas Southwestern Medical Center, Dallas, Texas, United States
๐บ๐ธUT Southwestern Medical Center, Dallas, Texas, United States
Hydroxycitrate: A Novel Therapy for Calcium Phosphate Urinary Stones
Phase 4
Recruiting
- Conditions
- Calcium Phosphate Kidney Stones
- Interventions
- Dietary Supplement: OHCit- low doseDrug: PlaceboDietary Supplement: OHCit- standard doseDrug: Potassium Citrate
- First Posted Date
- 2023-08-21
- Last Posted Date
- 2024-04-12
- Lead Sponsor
- University of Texas Southwestern Medical Center
- Target Recruit Count
- 25
- Registration Number
- NCT06003348
- Locations
- ๐บ๐ธ
UT Southwestern Medical Center, Dallas, Texas, United States
ยฉ Copyright 2025. All Rights Reserved by MedPath